These blood markers can expose colorectal, lung and ovarian cancers before symptoms appear

Biomarkers in the blood could be used for the early detection of colorectal cancer, lung cancer and ovarian cancer. A new study from Uppsala University shows that the performance of such biomarkers is comparable to or better than established tests and could be developed for clinical use.